AI-Driven Precision Medicine Market to Reach ~USD 9.7 Billion by 2035, Driven by Genomic AI Adoption, Personalized Therapies, and Digital Health Integration

Wilmington, DE, USA, 24th March 2026 - According to MarketGenics, the global AI-driven precision medicine market is valued at approximately USD 0.7 billion in 2025 and is projected to reach ~USD 9.7 billion by 2035, expanding at a CAGR of 26.8% during the forecast period (2025-2035).

This rapid growth is driven by increasing demand for personalized treatment approaches, rising adoption of AI in genomic analysis and diagnostics, and expanding integration of machine learning and real-time clinical decision systems across healthcare ecosystems.

For stakeholders across healthcare providers, pharmaceutical companies, and technology firms, AI-driven precision medicine represents a transformative shift toward data-driven, individualized care models that enhance treatment accuracy, reduce trial-and-error therapies, and improve patient outcomes.

Get Sample copy of the Report: https://marketgenics.co/download-report-sample/ai-driven-precision-medicine-market-41168

Market Highlights:
• Machine Learning (ML) accounts for approximately 39% of the global market in 2025, driven by its effectiveness in diagnosing and treating complex genetic diseases and cancers

• North America dominates with 62-67% market share, supported by advanced healthcare infrastructure, robust genomics research, and high adoption of AI technologies

• Top five players control over 64% of the market, indicating a moderately consolidated competitive landscape

Market Overview - Strategic Direction:
The AI-driven precision medicine market is evolving into a core pillar of next-generation healthcare, where artificial intelligence enables highly personalized, data-driven treatment pathways.

Growth is being accelerated by the rising need for early disease detection, real-time clinical decision-making, and targeted therapies, particularly in oncology, rare diseases, and chronic conditions.

Technologies such as machine learning, deep learning, natural language processing, and computer vision are enabling rapid analysis of genomic, clinical, and behavioral data, significantly improving diagnostic accuracy and treatment outcomes.

At the same time, integration with cloud-based platforms, wearable devices, and digital health ecosystems is expanding accessibility and scalability of precision medicine solutions globally.

Regional Insights - Global Growth Anchors:
• North America (Dominant Region):
North America accounts for 62-67% of global market share in 2025, with the United States leading innovation and adoption.

Regional Share Analysis, 2025

USA - ~89%

Canada

Mexico

The region's leadership is driven by:

Advanced digital health infrastructure

Strong investment in genomics and AI research

Supportive regulatory frameworks

Rapid adoption of AI-enabled diagnostic tools

• Asia Pacific & Europe:
Asia Pacific is emerging as a high-growth region, driven by expanding healthcare digitization, increasing investments in AI technologies, and rising adoption of precision medicine in emerging economies.

Europe continues to grow steadily due to regulatory support, research funding, and integration of AI in clinical workflows.

Competitive Landscape - Consolidation, Innovation, and Strategic Expansion:
The global AI-driven precision medicine market is moderately fragmented, with leading players competing through AI innovation, data ecosystem integration, and strategic healthcare collaborations.

Key Players Operating in the Global AI-Driven Precision Medicine Market:
• Berg Health

• Butterfly Network

• Caption Health

• Flatiron Health (Roche)

• Foundation Medicine (Roche)

• Freenome

• Genalyte

• Google Health / DeepMind

• Guardant Health

• IBM Watson Health

• Microsoft Healthcare (AI for Health)

• NVIDIA Corporation

• Oracle Health Sciences

• Owkin

• Paige AI

• PathAI

• Philips Healthcare

• Siemens Healthineers

• Tempus Labs

• Zebra Medical Vision

• Other Key Players

Market Dynamics - Drivers, Restraints, and Opportunities:
Driver: Growing adoption of AI in genomic analysis and personalized medicine

Restraint: High implementation costs, data privacy concerns, and regulatory complexities

Opportunity: Integration of predictive analytics and real-time clinical decision systems

Key Trend: Shift toward machine learning-driven precision diagnostics and treatment optimization

Market Segmentation - Comprehensive Coverage Across Value Chain:
By Technology Type
• Machine Learning (ML)

• Deep Learning (DL)

• Natural Language Processing (NLP)

• Computer Vision

• Reinforcement Learning

• Big Data Analytics

• Others

By Component
• Software
• Predictive Modeling
• Decision Support
• Others

• Services
• Implementation
• Consulting
• Data Management
• Others

• Hardware
• AI Chips
• Edge Devices
• Cloud Infrastructure
• Others

By Data Type
• Genomic Data

• Clinical Data (EHRs, Medical Imaging)

• Behavioral Data

• Environmental & Lifestyle Data

• Proteomic & Metabolomic Data

• Others

By Delivery Mode
• Cloud-based AI Solutions

• On-premise AI Systems

By Therapeutic Area
• Cancer

• Cardiovascular Diseases

• Neurological Disorders

• Infectious Diseases

• Others (Autoimmune, Endocrine Disorders)

By Application
• Oncology (Cancer Genomics, Tumor Profiling)

• Cardiology

• Neurology

• Immunology

• Pharmacogenomics

• Rare Diseases

• Infectious Diseases

• Others

By End User
• Hospitals & Clinics

• Research & Academic Institutions

• Pharmaceutical & Biotechnology Companies

• Clinical Laboratories

• Government & Public Health Agencies

• Others

By Region
• North America

• Europe

• Asia Pacific

• Middle East

• Africa

• South America

Key Highlights of the Report
• What is the current and projected market size of the global AI-driven precision medicine market through 2035?

• What are the key drivers, restraints, and opportunities shaping market growth?

• Which technologies such as machine learning are driving adoption?

• Which regions offer the highest growth potential, particularly North America?

• How is the competitive landscape evolving among key global players?

• What strategic priorities should stakeholders focus on for long-term value creation?

Research Methodology
The study is built on a robust, multi-layered research framework integrating both primary and secondary research to deliver highly accurate and strategically relevant insights. It combines demand-side analysis across healthcare providers, pharmaceutical companies, and research institutions with supply-side intelligence from technology developers and AI solution providers.

A combination of bottom-up and top-down approaches is employed, supported by rigorous data triangulation and validated through primary interactions with industry experts and stakeholders across key global regions.

Advanced analytical techniques-including regression modeling, time-series analysis, and scenario-based forecasting-are used to identify structural trends, demand shifts, and future growth opportunities.

Table of Contents - Key Areas Covered:
• Executive Summary & Market Overview

• Market Size & Forecast Analysis (2020-2035)

• Key Market Drivers, Restraints & Opportunities

• Segmentation Analysis (Technology, Material, End Use, etc.)

• Regional Analysis (North America, Europe, Asia Pacific, Middle East, Africa, South America)

• Country-Level Insights (Major Global Markets)

• Competitive Landscape & Company Profiles

• Emerging Trends (AI Diagnostics, Genomics, Digital Health Integration)

• Future Outlook & Strategic Recommendations

• Future Outlook & Strategic Recommendations

This report is particularly valuable for healthcare providers, pharmaceutical companies, biotechnology firms, research institutions, and AI technology developers seeking to enhance treatment precision, accelerate diagnostics, and capitalize on the rapidly evolving AI-driven healthcare ecosystem.

Access the full report and gain strategic insights to capitalize on emerging opportunities: https://marketgenics.co/reports/ai-driven-precision-medicine-market-41168

Recommended Reports:

Oral Biologics & Peptide Stabilization Market: https://marketgenics.co/reports/oral-biologics-peptide-stabilization-market-37608

Therapeutics & Biotech Niche Areas Market: https://marketgenics.co/reports/therapeutics-biotech-niche-areas-market-21559

Contact:

Mr. Nikhil Sawlani

MarketGenics Global Research

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617

Email: sales@marketgenics.co

Website: https://marketgenics.co

About MarketGenics

MarketGenics is a global market research and business advisory firm empowering decision-makers across startups, Fortune 500 companies, non-profit organizations, universities, and government institutions. The company delivers comprehensive market intelligence, industry analysis, and strategic insights across diverse sectors.

MarketGenics publishes detailed industry research reports combining granular quantitative analysis with expert insights on market trends, competitive landscapes, and emerging opportunities. These reports help organizations make informed strategic decisions, identify growth opportunities, and support sustainable business development.

In addition to research publications, MarketGenics supports organizations with strategic insights on product development, application modeling, market expansion strategies, and identifying niche growth opportunities.

This release was published on openPR.